Divakar Hemadri

Dr. Divakar Hemadri


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2020 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
SSShashi Bhushan Sudhakar
Shashi Bhushan Sudhakar
NMNiranjan Mishra
Niranjan Mishra
SKSemmannan Kalaiyarasu
Semmannan Kalaiyarasu
SJSandeep Kumar Jhade
Sandeep Kumar Jhade
DHDivakar Hemadri
Divakar Hemadri
VSVijendra Pal Singh
Vijendra Pal Singh

19 January 2011 in Virus Genes
Verified
Journal Article
Closed access
PDF file
Sharanagouda PatilSharanagouda Patil
Sharanagouda Patil
DHDivakar Hemadri
Divakar Hemadri
HVH. Veeresh
H. Veeresh
KSK. Sreekala
K. Sreekala
MGM. R. Gajendragad
M. R. Gajendragad
KPK. Prabhudas
K. Prabhudas

21 December 2016 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
DHDivakar Hemadri
Divakar Hemadri
SMS. Maan
S. Maan
MCM. M. Chanda
M. M. Chanda
PRP. P. Rao
P. P. Rao
KPK. Putty
K. Putty
PMP. P. C. Mertens
P. P. C. Mertens

22 February 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
Rakshit OjhaRakshit Ojha
Rakshit Ojha
Kirubakaran Vinod KumarKirubakaran Vinod Kumar
Kirubakaran Vinod Kumar
AAAnand Asha
Anand Asha
SUHAIL ASHRAFSUHAIL ASHRAF
SUHAIL ASHRAF
BGBaldev Raj Gulati
Baldev Raj Gulati
Peste des petits ruminants (PPR) presents economic challenges in enzootic countries impacting small ruminant productivity. The state of Karnataka, India, implemented a mass vaccination campaign in alignment with the PPR-Global Eradication Programme (GEP) and the National Strategic Plan for PPR eradication. This study was conducted from January to March 2023 to assess seroconversion in post-vaccinated goats and sheep at the epidemiological unit (epi-unit) level, aligning with the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) guidelines in the PPR Global Control and Eradication Strategy (GCES). Before vaccination, 3466 random serum samples were collected from small ruminants of three age groups (6–12 months, 1–2 years, and >2 years) across 116 epi-units, spanning 82 taluks in 28 districts. Post-vaccination sero-monitoring included 1102 serum samples collected from small ruminants of the 6–12-month age group only, across 111 epi-units covering 64 taluks in 23 districts. The PPRV antibody status was determined using an indigenous hemagglutinin (H) protein monoclonal antibody-based competitive ELISA kit. Pre-vaccination, the PPR seropositivity rates were 55%, 62%, and 66% in the age groups of 6–12 months, 1–2 years, and >2 years, respectively, with a 61% PPRV antibody prevalence across all the age groups. Notably, 41% of the epi-units exhibited antibody prevalence rates of ≥70%, indicating a substantial population immunity, possibly attributed to the previous vaccination program in the state since 2011. In contrast, only 17% of the epi-units had below 30% seroprevalence rates, emphasizing the need for intensified vaccination. Statistical analysis of the data revealed significant correlations (p < 0.05) between the presence of PPRV antibodies and host factors such as species, breed, and sex. Post-vaccination seroprevalence in the 6–12 months age group was found to be 73.4%, indicating the use of an efficacious vaccine. On the evaluation of vaccination immunity in the 6–12 months age group, it was revealed that over 69% of the epi-units achieved a response surpassing ≥70%, indicating a significant improvement from 42% of the epi-units in pre-vaccination. For active PPR eradication, a mass vaccination campaign (>95% coverage) targeting small ruminant populations aged >4 months is advocated, aiming to achieve the desired herd immunity of >80%. This study offers crucial insights into PPR baseline seroprevalence/immunity status and vaccine efficacy, guiding national strategies towards a PPR-free India and further supporting the global eradication initiative.

13 March 2018 in Veterinary World
Verified
Journal Article
Open access
Sharanagouda PatilSharanagouda Patil
Sharanagouda Patil
KSK. P. Suresh
K. P. Suresh
SSS. Saha
S. Saha
APA. Prajapati
A. Prajapati
DHDivakar Hemadri
Divakar Hemadri
PRP. Roy
P. Roy
The aim of the study was to determine the overall prevalence of classical swine fever (CSF) in pigs in India, through a systematic review and meta-analysis of published data

29 October 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
PSPriyansha Raj Sinha
Priyansha Raj Sinha
SHShubhada Hegde
Shubhada Hegde
RMRuchika Mittal
Ruchika Mittal
CJChikkamagaluru Chandrashekhar Jagat
Chikkamagaluru Chandrashekhar Jagat
UGUllas Gowda
Ullas Gowda
DHDivakar Hemadri
Divakar Hemadri
The bluetongue virus (BTV), transmitted by biting midges, poses a significant threat to livestock globally. This orbivirus induces bluetongue disease, leading to substantial economic losses in the agricultural sector. The current control measures have limitations, necessitating the development of novel, efficient vaccines. In this study, an immunoinformatics approach is employed to design a multi-epitope subunit vaccine for Ovis aries targeting six BTV serotypes. Focusing on the VP2 capsid protein, the vaccine incorporates B-cell, helper-T lymphocytes (HTL), and cytotoxic T-cell lymphocytes (CTL) epitopes. Molecular docking reveals stable interactions with TLR2 and TLR4 receptors, suggesting the stability of the complex, indicating the potential viability of the multi-epitope vaccine. The computational approach offers a rapid and tailored strategy for vaccine development, highlighting potential efficacy and safety against BTV outbreaks. This work contributes to understanding BTV and presents a promising avenue for effective control.